Background: Malaria is a major public health problem globally and resistance to most widely used drugs impedes its control. Artemisinin resistance has emerged and spread in the Greater Mekong Sub region (GMS), followed by artemisinin-based combination therapies (ACTs)’ treatment failure, due to both…

Background

Home care professionals are more at risk for health problems than usual in hot weather, as their clients are particularly vulnerable to the heat, need more care and thus require more effort. Second, the work of home care professionals consists of physically demanding and cognitively…

Background:
Population trust in health systems is crucial both during public health crises like the COVID-19 pandemic and during normal times, as it influences people’s willingness to contribute resources to the health system, to utilize the services it offers, and to follow public health guidance.…

The raison d’être of Anesvad is to improve the health of the most neglected people and communities. A major ongoing quest is the fight against neglected tropical diseases (NTDs) with a focus on skin NTDs through health system strengthening (HSS) from a human rights perspective. This is outlined in…

Swiss TPH provides technical assistance to country organisations currently engaged in the implementation of Global Financing Facility (GFF) Investment Case (IC) evaluations, with the aim to strengthen their capacities to conduct high quality evaluations. Focusing on reproductive, maternal, newborn,…

Noul Inc, a South Korean start-up, has developed the miLab(TM) platform, which allows automated sample preparation to imaging and AI analysis of small amounts of blood samples. The platform is of potential high interested for malaria control, namely malaria diagnostics in low- and middle-income…

Tuberculosis (TB) remains one of the most important global health problems. With the COVID-19 pandemic receding, TB is once again the number one cause of human mortality due to infection. Moreover, multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB) are among the most frequent…

In 2018, the Gavi Board approved the inclusion of Rabies Post-Exposure Prophylaxis (PEP) into the portfolio of vaccines to be funded in the 2021-2025 strategic period. Various challenges were identified in relation to its operationalisation leading to the elaboration of the 2018 VIS Rabies learning…

IMCI-PLUS is an inter-disciplinary, Pan-African-EU research partnership, with emphasis on capacity strengthening and mutual learning, to improve management of pediatric lower respiratory tract infections (LRTI) – the leading cause of child morbidity and mortality in Sub-Saharan Africa (SSA) – by…

The WHO Department of Maternal, Newborn, Child and Adolescent Health and Ageing (WHO/MCA) will coordinate a multi-country, multi-centre randomised controlled trial to evaluate the effect of approaches to prevent and manage growth faltering in the first six months of life on wasting-free survival at…